XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation Plans (Tables)
6 Months Ended
Jun. 30, 2020
Share-Based Compensation Plans  
Schedule of Company's stock option activity

The following table summarizes the Company’s stock option activity for the six-month period ended June 30, 2020:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

    

Shares

    

Price

    

Term (Years)

    

Value*

Outstanding at December 31, 2019

 

1,176,770

$

27.14

 

  

 

  

Granted

 

$

 

  

 

  

Exercised

 

$

 

  

 

  

Forfeited or expired

 

(9,135)

$

28.03

 

  

 

  

Outstanding at June 30, 2020

 

1,167,635

$

27.13

 

4.2

$

Exercisable at June 30, 2020

 

700,655

$

26.70

 

1.9

$

*     The aggregate intrinsic value of outstanding and exercisable stock options is defined as the difference between the market value of the Company's stock on June 30, 2020, the last trading day of the quarter, of $21.59 and the exercise price multiplied by the number of in-the-money outstanding and exercisable stockoptions. The respective exercise prices of all of the Company's outstanding stock options were higher than the closing price of the Company's common stock as of June 30, 2020; therefore, the aggregate intrinsic value of the Company's stock options is zero.

Schedule of Company's stock option exercise activity

The following table summarizes the Company’s stock option exercise activity for the three and six months ended June 30, 2020 and 2019:

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2020

    

2019

    

2020

    

2019

(Dollars in thousands)

Total intrinsic value of stock options exercised

$

$

77

$

$

88

Net proceeds from stock option exercises

$

$

154

$

$

161

Income tax benefit from the exercise of stock options

$

$

20

$

$

23

Schedule of Company's restricted stock award

The following table summarizes the Company’s restricted stock award activity for the six-month period ended June 30, 2020:

Weighted

Weighted

Average

Shares of

Average

Remaining

Aggregate

Restricted

Grant Date

Contractual

Intrinsic

    

Stock

    

Fair Value

    

Term (Years)

    

Value*

Non-vested at December 31, 2019

 

68,735

$

28.04

 

  

 

  

Issued

 

 

  

 

  

Vested

 

 

 

  

 

  

Forfeited

 

 

 

  

 

  

Non-vested at June 30, 2020

 

68,735

$

28.04

 

2.2

$

1,484,000

*     The aggregate intrinsic value of non-vested restricted stock was calculated using the market value of the Company's stock on June 30, 2020, the last trading day of the quarter, of $21.59 multiplied by the number of non-vested restricted shares outstanding.